Fischer Medical Ventures Ltd — Important, 02-01-2026: Company Update
02-01-2026 | 10:27 am
02-01-2026 | 10:27 am
Fischer Medical Ventures Limited's Board has reconstituted its Audit Committee, Nomination and Remuneration Committee, Risk Management Committee, and Corporate Social Responsibility Committee. This restructuring enhances corporate governance by updating the composition of these vital oversight functions. The revised committees include a mix of independent directors, the managing director, whole-time directors, and key executives, aiming for robust decision-making and strategic direction in areas like financial integrity, executive appointments, risk management, and social impact.
No comments yet. Be the first to comment!
